Five artificial intelligence (AI) technologies designed to act as a "second pair of eyes" during colonoscopies have been conditionally recommended for NHS use by the National Institute for Health and ...

Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for ...

Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for early ...

Abdus Sobur receives a 2025 Global Recognition Award for developing artificial intelligence models that support earlier ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...

The firm has developed a whole-blood mRNA test intended for use as a screening tool in women at elevated risk of breast cancer.